BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16267247)

  • 1. Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs.
    Colan SD
    Circulation; 2005 Nov; 112(18):2756-8. PubMed ID: 16267247
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP
    Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
    [No Abstract]   [Full Text] [Related]  

  • 4. Left ventricular aneurysm in a patient with Duchenne muscular dystrophy.
    Fayssoil A; Abdallah C; Orlikowski D
    Presse Med; 2014 Jun; 43(6 Pt 1):731-2. PubMed ID: 24525307
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
    Fayssoil A
    Indian Heart J; 2010; 62(3):273. PubMed ID: 21275309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracardiac thrombus and cerebral infarction in a patient with duchenne muscular dystrophy.
    Gimenez-Muñoz A; Capablo JL; Alarcia R; Torné L; Errea JM
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):79-80. PubMed ID: 19955989
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
    Haddad CN; Ali S; Stephanou D; Assakura MS; Sahagian L; Trogkanis E
    Hellenic J Cardiol; 2023; 74():58-64. PubMed ID: 37406964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.
    Kaspar RW; Allen HD; Montanaro F
    J Am Acad Nurse Pract; 2009 May; 21(5):241-9. PubMed ID: 19432907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up to date in pharmacological treatment of dilated cardiomyopathy.
    Ginghina C; Teodorescu A; Stoian I; Serban M; Ghiorghiu I; Wohlfart K
    Rom J Intern Med; 2004; 42(1):3-13. PubMed ID: 15529591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated cardiomyopathy : clinical profile and treatment.
    Khalil A; Chawla K; Chakravarti A
    Indian Pediatr; 2000 Nov; 37(11):1242-6. PubMed ID: 11086307
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete atrioventricular block in Becker muscular dystrophy.
    Akdemir R; Ozhan H; Gunduz H; Yazici M; Erbilen E; Uyan C; Imirzalioglu N
    N Z Med J; 2004 May; 117(1194):U895. PubMed ID: 15156213
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral infarction in Duchenne muscular dystrophy.
    Tsakadze N; Katzin LW; Krishnan S; Behrouz R
    J Stroke Cerebrovasc Dis; 2011; 20(3):264-5. PubMed ID: 20621521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.
    Finsterer J; Stöllberger C
    Neuromuscul Disord; 2009 Jan; 19(1):74; author reply 75. PubMed ID: 19070488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
    Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results.
    Politano L; Nigro G
    Acta Myol; 2012 May; 31(1):24-30. PubMed ID: 22655514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the pathophysiology is the key to novel therapies for canine dilated cardiomyopathy.
    Elliott J; Marr CM
    Vet J; 2001 Nov; 162(3):168-9. PubMed ID: 11681866
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial A3243G mutation with manifestation of acute dilated cardiomyopathy.
    Stalder N; Yarol N; Tozzi P; Rotman S; Morris M; Fellmann F; Schwitter J; Hullin R
    Circ Heart Fail; 2012 Jan; 5(1):e1-3. PubMed ID: 22253408
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mitochondrial cardiomyopathy].
    Tanaka M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():306-11. PubMed ID: 12013873
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress in the treatment of myocardial diseases].
    Toshima H
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):363-6. PubMed ID: 1970599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.